Reese Headache Powders
NDC 10956-501, Aspirin and Caffeine, powder, from Reese Pharmaceutical Co.
- Product NDC
- 10956-501
- Status
- Listed
- Labeler
- Reese Pharmaceutical Co
- Dosage form
- POWDER
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M013
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10956-501 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CAFFEINE65 mg/1
- ASPIRIN845 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS]; Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]; Cyclooxygenase Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; Decreased Prostaglandin Production [PE]; Methylxanthine [EPC]; Nonsteroidal Anti-inflammatory Drug [EPC]; Platelet Aggregation Inhibitor [EPC]; Xanthines [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10956-501-18 | 10956050118 | 18 PACKET in 1 CARTON (10956-501-18) / 1 POWDER in 1 PACKET |
| 10956-501-24 | 10956050124 | 24 PACKET in 1 CARTON (10956-501-24) / 1 POWDER in 1 PACKET |
| 10956-501-50 | 10956050150 | 50 PACKET in 1 CARTON (10956-501-50) / 1 POWDER in 1 PACKET |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 10956-501 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10956-501 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10956-501. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.